Hormone-Refractory Prostate Cancer Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02955082The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer TreatmentTreatment